Your browser doesn't support javascript.
loading
Synthetic FLAIR as a Substitute for FLAIR Sequence in Acute Ischemic Stroke.
Benzakoun, Joseph; Deslys, Marc-Antoine; Legrand, Laurence; Hmeydia, Ghazi; Turc, Guillaume; Hassen, Wagih Ben; Charron, Sylvain; Debacker, Clément; Naggara, Olivier; Baron, Jean-Claude; Thirion, Bertrand; Oppenheim, Catherine.
Afiliação
  • Benzakoun J; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Deslys MA; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Legrand L; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Hmeydia G; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Turc G; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Hassen WB; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Charron S; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Debacker C; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Naggara O; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Baron JC; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Thirion B; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
  • Oppenheim C; From the Departments of Neuroradiology (J.B., L.L., G.H., W.B.H., O.N., C.O.) and Neurology (G.T., J.C.B.), GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, 1 rue Cabanis, 75014 Paris, France; INSERM U1266, Paris, France (J.B., M.A.D., L.L., G.T., W.B.H., S.C., C.D., O.N., J.C.B., C.O.); Un
Radiology ; 303(1): 153-159, 2022 04.
Article em En | MEDLINE | ID: mdl-35014901
ABSTRACT
Background In acute ischemic stroke (AIS), fluid-attenuated inversion recovery (FLAIR) is used for treatment decisions when onset time is unknown. Synthetic FLAIR could be generated with deep learning from information embedded in diffusion-weighted imaging (DWI) and could replace acquired FLAIR sequence (real FLAIR) and shorten MRI duration. Purpose To compare performance of synthetic and real FLAIR for DWI-FLAIR mismatch estimation and identification of patients presenting within 4.5 hours from symptom onset. Materials and Methods In this retrospective study, all pretreatment and early follow-up (<48 hours after symptom onset) MRI data sets including DWI (b = 0-1000 sec/mm2) and FLAIR sequences obtained in consecutive patients with AIS referred for reperfusion therapies between January 2002 and May 2019 were included. On the training set (80%), a generative adversarial network was trained to produce synthetic FLAIR with DWI as input. On the test set (20%), synthetic FLAIR was computed without real FLAIR knowledge. The DWI-FLAIR mismatch was evaluated on both FLAIR data sets by four independent readers. Interobserver reproducibility and DWI-FLAIR mismatch concordance between synthetic and real FLAIR were evaluated with κ statistics. Sensitivity and specificity for identification of AIS within 4.5 hours were compared in patients with known onset time by using McNemar test. Results The study included 1416 MRI scans (861 patients; median age, 71 years [interquartile range, 57-81 years]; 375 men), yielding 1134 and 282 scans for training and test sets, respectively. Regarding DWI-FLAIR mismatch, interobserver reproducibility was substantial for real and synthetic FLAIR (κ = 0.80 [95% CI 0.74, 0.87] and 0.80 [95% CI 0.74, 0.87], respectively). After consensus, concordance between real and synthetic FLAIR was almost perfect (κ = 0.88; 95% CI 0.82, 0.93). Diagnostic value for identifying AIS within 4.5 hours did not differ between real and synthetic FLAIR (sensitivity 107 of 131 [82%] vs 111 of 131 [85%], P = .2; specificity 96 of 104 [92%] vs 96 of 104 [92%], respectively, P > .99). Conclusion Synthetic fluid-attenuated inversion recovery (FLAIR) had diagnostic performances similar to real FLAIR in depicting diffusion-weighted imaging-FLAIR mismatch and in helping to identify early acute ischemic stroke, and it may accelerate MRI protocols. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Carroll and Hurley in this issue.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article